|
Recent Developments |
|
19-FEB-13
GlaxoSmithKline Pharmaceuticals (GSK Pharma), a research-based pharmaceutical and healthcare company, today reported a marginal rise of 1.29% in net profit for the quarter ended December 2012.
09-NOV-12
GlaxoSmithKline Pharmaceuticals (GSK Pharma), a research-based pharmaceutical and healthcare company, today reported a rise of 4.44% in net profit for the quarter ended September, 2012.
13-AUG-12
GlaxoSmithKline Pharmaceuticals (GSK ... More.. |
| Business Profile |
Future Plans |
|
|
|
|
One To One
|
|
Recent news
|
|
|
| Period ending (months) | 31-Dec-2012 (12) | 31-Dec-2011 (12) | 31-Dec-2010 (12) | | Net sales | 25999.30 | 23380.30 | 21116.40 | | Other Income | 1934.80 | 180.00 | 180.00 | | Total Income | 27934.10 | 23560.30 | 21296.40 | | Cost of goods sold | 18111.60 | 15935.00 | 13738.50 | | OPBDIT | 9822.50 | 7625.30 | 7557.90 | | PAT | 5772.60 | 4306.00 | 5636.90 | | Gross Block | - | - | - | | Equity capital | 847.00 | 847.00 | 847.00 | | EPS (Rs.) | 68.20 | 0.00 | 66.60 | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | 28.09 - 34.28 | NA | 22.37 - 35.90 | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | 35.2 | 32.4 | 35.5 | | Net margin (% of OI) | 20.7 | 18.3 | 26.5 |
|
|
Detailed Financials
|
|
|
|
|
Snapshot
